Colistimethate

Active Ingredient(s): Colistimethate Sodium
FDA Approved: * February 26, 1999
Pharm Company: * PHARMA TEK
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Colistimethate Overview

Colistin, also known as polymyxin E, is an antibiotic used as a last-resort for multidrug-resistant Gram negative infections including pneumonia.[1][2] These may involve bacteria such as Pseudomonas aeruginosa, Klebsiella pneumoniae, or Acinetobacter.[3] It comes in a form which can be injection into a vein or muscle or inhaled, known as colistimethate sodium and one which is applied to the skin or taken by mouth, known as colistin sulfate.&...

Read more Colistimethate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Colistin

Recent Colistimethate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Colistimethate Sodium
  • Injection: 150mg, 150mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Colistimethate: (9 results)

Sorted by National Drug Code
  • 0574-0858 Colistimethate 150 mg/2ml Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Paddock Laboratories, LLC
  • 23155-193 Colistimethate Sodium 150 mg/4ml Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Heritage Pharmaceuticals Inc.
  • 25021-159 Colistimethate 150 mg/2ml Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 39822-0615 Colistimethate 150 mg/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by X-gen Pharmaceuticals, Inc.
  • 39822-0617 Colistimethate 150 mg/2ml Intramuscular; Intravenous Injection by X-gen Pharmaceuticals, Inc.
  • 42023-131 Colistimethate 150 mg/2ml Intramuscular; Intravenous Injection by Jhp Pharmaceuticals, LLC
  • 45932-0023 Colistimethate 150 mg/2ml Intramuscular; Intravenous Injection by Xellia Pharmaceuticals Aps
  • 63323-393 Colistimethate 150 mg/2ml Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 70594-023 Colistimethate 150 mg Intramuscular; Intravenous Injection, Powder, for Solution by Xellia Pharmaceuticals USA LLC

Other drugs which contain Colistimethate Sodium or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 September 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA